Emily Wheeler is Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO). Ms. Wheeler is responsible for working with member companies engaged in antimicrobial research, development, and commercialization, and leads BIO’s antimicrobial resistance (AMR) legislative and regulatory policy efforts. She is also the Director of the Working to Fight AMR public awareness campaign. Ms. Wheeler serves on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) and is a member of the Stakeholder Group for the Global AMR R&D Hub. She represents the biotechnology sector as Board member on the AMR Industry Alliance (AMRIA) and is co-Chair of AMRIA’s Research and Science Working Group.
Recorded remarks from Congressman Mike Levin
Explore the future of AMR policy development with insights on sustaining innovation, ensuring global access, and overcoming implementation challenges. Join us for a discussion on effective strategies and interdisciplinary collaborations to combat antimicrobial resistance.